Publicaciones en colaboración con investigadores/as de Hospital Universitario Arnau de Vilanova (22)

2023

  1. The Prognostic Significance of Tumor-Infiltrating Lymphocytes, PD-L1, BRCA Mutation Status and Tumor Mutational Burden in Early-Stage High-Grade Serous Ovarian Carcinoma-A Study by the Spanish Group for Ovarian Cancer Research (GEICO)

    International journal of molecular sciences, Vol. 24, Núm. 13

2022

  1. Comparison of the Idylla™ MSI assay with the Promega™ MSI Analysis System and immunohistochemistry on formalin-fixed paraffin-embedded tissue of endometrial carcinoma: results from an international, multicenter study

    Virchows Archiv, Vol. 480, Núm. 5, pp. 1031-1039

  2. Impact of the COVID-19 pandemic on pathology training: a survey among Spanish residents

    Virchows Archiv, Vol. 481, Núm. 3, pp. 505-509

2019

  1. Clinical challenges and implications of intratumor heterogeneity

    Revista Espanola de Patologia, Vol. 52, Núm. 4, pp. 234-241

  2. Molecular basis of tumor heterogeneity in endometrial carcinosarcoma

    Cancers, Vol. 11, Núm. 7

2016

  1. Massively Parallel Sequencing-Based Clonality Analysis of Synchronous Endometrioid Endometrial and Ovarian Carcinomas

    Journal of the National Cancer Institute, Vol. 108, Núm. 6

2015

  1. A role for the transducer of the Hippo pathway, TAZ, in the development of aggressive types of endometrial cancer

    Modern Pathology, Vol. 28, Núm. 11, pp. 1492-1503

2014

  1. A 9-protein biomarker molecular signature for predicting histologic type in endometrial carcinoma by immunohistochemistry

    Human Pathology, Vol. 45, Núm. 12, pp. 2394-2403

2013

  1. Endometrial carcinoma: Molecular alterations involved in tumor development and progression

    Oncogene, Vol. 32, Núm. 4, pp. 403-413

  2. Molecular events in endometrial carcinosarcomas and the role of high mobility group AT-hook 2 in endometrial carcinogenesis

    Human Pathology, Vol. 44, Núm. 2, pp. 244-254

  3. ZEB1 overexpression associated with E-cadherin and microRNA-200 downregulation is characteristic of undifferentiated endometrial carcinoma

    Modern Pathology, Vol. 26, Núm. 11, pp. 1514-1524

2012

  1. Immunohistochemical features of post-radiation vaginal recurrences of endometrioid carcinomas of the endometrium: Role for proteins involved in resistance to apoptosis and hypoxia

    Histopathology, Vol. 60, Núm. 3, pp. 460-471

2011

  1. KSR1 is overexpressed in endometrial carcinoma and regulates proliferation and TRAIL-induced apoptosis by modulating FLIP levels

    American Journal of Pathology, Vol. 178, Núm. 4, pp. 1529-1543

  2. Micro-RNA signature of the epithelial-mesenchymal transition in endometrial carcinosarcoma

    Journal of Pathology, Vol. 223, Núm. 1, pp. 72-80

2009

  1. Guidelines for HER2 testing in breast cancer. A national consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology

    Revista Espanola de Patologia, Vol. 42, Núm. 1, pp. 3-16

2006

  1. PIK3CA gene mutations in endometrial carcinoma. Correlation with PTEN and K-RAS alterations

    Human Pathology, Vol. 37, Núm. 11, pp. 1465-1472

2005

  1. Immunohistochemical analysis of PTEN in endometrial carcinoma: A tissue microarray study with a comparison of four commercial antibodies in correlation with molecular abnormalities

    Modern Pathology, Vol. 18, Núm. 5, pp. 719-727

  2. Survivin expression in endometrial carcinoma: A tissue microarray study with correlation with PTEN and STAT-3

    International Journal of Gynecological Pathology, Vol. 24, Núm. 3, pp. 247-253

2004

  1. Abnormalities in the NF-κB family and related proteins in endometrial carcinoma

    Journal of Pathology, Vol. 204, Núm. 5, pp. 569-577

2003

  1. Abnormalities of E- and P-cadherin and catenin (β-, γ-catenin, and p120ctn) expression in endometrial cancer and endometrial atypical hyperplasia

    Journal of Pathology, Vol. 199, Núm. 4, pp. 471-478